Evidence map›Paper›PMID 33494414›Full record

ArticleGenes2021

Characterization of New

Sandra Parenti, Claudio Rabacchi, Marco Marino, Elena Tenedini, Lucia Artuso, Sara Castellano, Chiara Carretta, Selene Mallia, Laura Cortesi, Angela Toss and 5 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Identification and Characterization of an Exonic Duplication inInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Sandra ParentiCenter for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Claudio RabacchiCenter for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Marco MarinoDepartment of Laboratory Medicine and Pathology, Diagnostic hematology and Clinical Genomics Unit, Modena University Hospital, 41124 Modena, Italy.
Elena TenediniDepartment of Laboratory Medicine and Pathology, Diagnostic hematology and Clinical Genomics Unit, Modena University Hospital, 41124 Modena, Italy.
Lucia ArtusoDepartment of Laboratory Medicine and Pathology, Diagnostic hematology and Clinical Genomics Unit, Modena University Hospital, 41124 Modena, Italy.
Sara CastellanoDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Chiara CarrettaCentre for Regenerative Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Selene MalliaCentre for Regenerative Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Laura CortesiDepartment of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy.
Angela TossDepartment of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy.ORCID 0000-0002-1854-6701
Elena BarbieriDepartment of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy.
Rossella ManfrediniCentre for Regenerative Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Mario LuppiDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Tommaso TrentiDepartment of Laboratory Medicine and Pathology, Diagnostic hematology and Clinical Genomics Unit, Modena University Hospital, 41124 Modena, Italy.
Enrico TagliaficoCentre for Regenerative Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0003-0981-2542
University of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation sequencing (NGS)-based cancer risk screening with multigene panels has become the most successful method for programming cancer prevention strategies.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseSequence DeletionAllelesAtaxia Telangiectasia Mutated ProteinsBreast NeoplasmsChromosome BreakpointsFemaleGene Expression Regulation, NeoplasticGenetic LociGenetic TestingGenetic VariationGenotypeHigh-Throughput Nucleotide SequencingHumansMiddle AgedAtaxia Telangiectasia Mutated ProteinsATM protein, humanRNA, MessengerATMbreast cancerclinical genomicshereditary cancer syndromeshomologous recombination repairmolecular diagnosticsnext-generation sequencing

Identifiers

PMID33494414
PMCPMC7911716
OpenAlexW3124649477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.